MedPath

Safety and Efficacy of Bronchitol in Bronchiectasis

Phase 3
Completed
Conditions
Bronchiectasis
Interventions
Drug: placebo
Registration Number
NCT00277537
Lead Sponsor
Syntara
Brief Summary

Study will assess the safety and effectiveness of 12 week treatment with the study medication, Bronchitol, in subjects with bronchiectasis (a lung disease where patients have trapped, and often infected, thick, sticky mucus). Past studies have shown Bronchitol inhalation may help to facilitate the clearance of mucus by altering its rheology (making it less thick and sticky), thereby enhancing the shift of stagnant mucus from the lungs. On completion of the double blind phase, subjects will have the opportunity to participate in a 52 week open label phase.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
354
Inclusion Criteria
  • Non cystic fibrosis bronchiectasis
  • Have FEV1 50% - 80% predicted and ≥1.0L
  • Have chronic sputum production of >10 mL per day on the majority of days in the 3 months prior to study entry
Exclusion Criteria
  • Be using hypertonic saline or mucolytic pharmacological agents concurrently or in the 4 weeks prior to study entry
  • Have airway hyperresponsiveness as defined by a positive Aridol challenge

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2placebo-
1Mannitol-
Primary Outcome Measures
NameTimeMethod
24 hour sputum clearance24 hours / 12 weeks
Quality of Life SGRQ12 weeks
Secondary Outcome Measures
NameTimeMethod
cough severity12 weeks
bronchial wall thickening and inflammation12 weeks
bronchiectasis symptoms12 weeks
exercise capacity12 weeks
lung function, including gas transfer12 weeks
antibiotic use12 weeks
haematology, biochemistry,12 weeks / 12 months
sputum microbiology quantitative and qualitative12 weeks / 12 months
adverse events12 weeks / 12 months

Trial Locations

Locations (22)

Canberra Hospital

🇦🇺

Canberra, Australian Capital Territory, Australia

Royal Prince Alfred Hospital

🇦🇺

Camperdown Sydney, New South Wales, Australia

St George Hospital

🇦🇺

Kogarah, New South Wales, Australia

John Hunter Hospital

🇦🇺

Newcastle, New South Wales, Australia

Royal North Shore Hospital

🇦🇺

St Leonards, New South Wales, Australia

Bankstown Hospital

🇦🇺

Sydney, New South Wales, Australia

Mater Adult Hospital

🇦🇺

Brisbane, Queensland, Australia

Cairns Base Hospital

🇦🇺

Cairns, Queensland, Australia

Repatriation General Hospital

🇦🇺

Adelaide, South Australia, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Scroll for more (12 remaining)
Canberra Hospital
🇦🇺Canberra, Australian Capital Territory, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.